Pulmonary Hypertension Program

The Pulmonary Hypertension Program is a premier, comprehensive care center offered through the Mount Sinai National Jewish Health Respiratory Institute. This unique partnership brings together nationally renowned pulmonologists, cardiologists, rheumatologists, clinical nurse specialists, pharmacists, nutritionists, and social workers in a multidisciplinary program. We offer a full range of diagnostic and therapeutic services to patients with all forms of pulmonary hypertension, including pulmonary arterial hypertension.

Types and Causes of Pulmonary Hypertension

Patients with pulmonary hypertension fall under the category of one of five groups. These groups are:

Group 1 – Pulmonary Arterial Hypertension

  • Congenital heart disease
  • Connective Tissue Disease (scleroderma, lupus, etc.)
  • Drug and toxin Induced
  • Familial
  • HIV
  • Idiopathic
  • Portal Hypertension

Group 2 – Left Heart Disease

This is often a result of:

  • Age
  • Coronary artery disease
  • Damage to the heart muscle
  • Diabetes
  • Heart valve disease
  • High blood pressure
  • Obesity

Group 3 – Lung Disease

Pulmonary vessels are tightened in response to other lung diseases, such as:

  • COPD
  • Interstitial lung disease

Group 4 – Chronic Thromboembolic Pulmonary Hypertension

PH caused by old, organized blood clots in the lungs that form a physical barrier to blood flow within the pulmonary arteries.

Group 5 – PH Resulting from Unclear Multifactorial Mechanisms

These diseases include:

  • Blood disease (sickle cell anemia, chronic hemolytic anemia, etc.)
  • History of spleen removal
  • Kidney disease
  • Metabolic disease (Gaucher disease, thyroid disease)
  • Sarcoidosis

Treatments for Pulmonary Hypertension

We offer multiple treatment options for all forms of pulmonary hypertension. Medications such as pills, inhalers, and infusions developed specifically for the treatment of PH to dilate, and reduce the inappropriate growth of cells in the pulmonary arteries. These therapies ultimately allow the heart to function more efficiently.  

Why Mount Sinai – National Jewish Health Respiratory Institute

The Mount Sinai – National Jewish Health Respiratory Institutebringsa multidisciplinary and patient-centered approach to the management of pulmonary hypertension. We ensure that patients fully understand the nature of their condition and its treatment.

Our program offers and has extensive experience using all FDA-approved medications to treat pulmonary hypertension, including oral, inhaled, subcutaneous, and intravenous medications.As a patient, you can be assured that you’ll have access to the latest treatments and leading experts from every discipline. Feel confident that you have an exceptional team, committed to your care.